Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.

Popular Topics

  • Virtual and digital health
  • Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
  • Value-based healthcare 
  • Precision and stratified medicine
  • Integration of digital technology into existing workflow and procedures 
  • Next-generation immuno, cell, and gene therapies
  • Vaccines
  • Biomarkers, sequencing, and imaging
  • Rare diseases
  • MedTech and medical devices
  • Clinical trials
  • Addressing Social Determinants of Health
  • Treating chronic conditions like obesity and pain
  • Clinician and staff burnout

The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors. 

 

Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.

Empowered Patient Solutions

Apr 26, 2021

Dr. R.J. Tesi, President and CEO, INmune Bio shines light on the complexity of the immune system by pointing out that while much work has been done on the adaptive immune system, the key to treating Alzheimer's might be to address the dysregulated innate immune system due to chronic inflammation. R.J. talks about developing XPro1595 a second generation selective TNF inhibitor which is designed to reduce inflammatory activity in the brain. They are also validating novel neuroimaging techniques and biomarkers to help predict which patients may respond to treating neuroinflammation as an underlying cause of their Alzheimer's.

@INmuneBio #neuroinflammation #Alzheimers #cytokine #biotech #clinicaltrial #biomarkers #InnateImmuneSystem

INmuneBio.com

Listen to the podcast here

INmune